TESSARI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 13.332
AS - Asia 6.504
EU - Europa 3.629
AF - Africa 1.077
SA - Sud America 992
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 60
Totale 25.699
Nazione #
US - Stati Uniti d'America 12.804
SG - Singapore 2.239
IT - Italia 1.339
CN - Cina 1.206
HK - Hong Kong 736
VN - Vietnam 706
BR - Brasile 598
FR - Francia 279
FI - Finlandia 265
DE - Germania 252
IN - India 216
SE - Svezia 160
GB - Regno Unito 148
UA - Ucraina 135
IQ - Iraq 132
TR - Turchia 99
RU - Federazione Russa 97
BD - Bangladesh 96
NL - Olanda 96
PL - Polonia 96
AR - Argentina 86
JP - Giappone 68
PH - Filippine 68
PK - Pakistan 68
ID - Indonesia 63
ZA - Sudafrica 56
MX - Messico 55
SA - Arabia Saudita 55
EC - Ecuador 53
UZ - Uzbekistan 51
CA - Canada 49
BJ - Benin 47
IE - Irlanda 47
MY - Malesia 44
AO - Angola 43
CO - Colombia 41
KE - Kenya 40
MA - Marocco 40
KG - Kirghizistan 39
ES - Italia 38
BE - Belgio 36
CL - Cile 36
CW - ???statistics.table.value.countryCode.CW??? 36
JO - Giordania 36
GR - Grecia 35
PS - Palestinian Territory 35
UG - Uganda 35
VE - Venezuela 35
AZ - Azerbaigian 34
BG - Bulgaria 34
NG - Nigeria 34
PE - Perù 34
AL - Albania 33
CZ - Repubblica Ceca 33
DZ - Algeria 33
GT - Guatemala 33
PT - Portogallo 33
TH - Thailandia 33
TN - Tunisia 32
AU - Australia 30
BY - Bielorussia 30
CV - Capo Verde 30
ET - Etiopia 30
NO - Norvegia 30
PY - Paraguay 30
AM - Armenia 29
HN - Honduras 29
IL - Israele 29
MN - Mongolia 29
RO - Romania 29
UY - Uruguay 29
CH - Svizzera 28
CR - Costa Rica 28
GA - Gabon 28
LA - Repubblica Popolare Democratica del Laos 28
LV - Lettonia 28
LY - Libia 28
MD - Moldavia 28
NP - Nepal 28
AE - Emirati Arabi Uniti 27
AT - Austria 27
DO - Repubblica Dominicana 27
EG - Egitto 27
GH - Ghana 27
KH - Cambogia 27
KZ - Kazakistan 27
LB - Libano 27
MZ - Mozambico 27
PA - Panama 27
ZW - Zimbabwe 27
CD - Congo 26
CG - Congo 26
IR - Iran 26
ME - Montenegro 26
MR - Mauritania 26
NI - Nicaragua 26
GF - Guiana Francese 25
KR - Corea 25
LU - Lussemburgo 25
NZ - Nuova Zelanda 25
Totale 24.531
Città #
Fairfield 1.596
Ashburn 1.515
Singapore 1.420
Woodbridge 1.224
San Jose 1.156
Chandler 726
Houston 675
Hong Kong 674
Seattle 630
Wilmington 571
Ann Arbor 556
Cambridge 550
Jacksonville 450
Princeton 246
Santa Clara 239
Boardman 215
Beijing 211
Ho Chi Minh City 203
Los Angeles 173
San Diego 162
Hanoi 150
Lauterbourg 135
Roxbury 134
Milan 114
New York 107
Helsinki 102
Nanjing 100
Padova 100
Rome 99
Des Moines 87
Dong Ket 85
Medford 83
Council Bluffs 73
Munich 70
Bytom 60
Guangzhou 59
Tashkent 50
São Paulo 49
Baghdad 45
Cotonou 45
Shenyang 40
Chicago 38
Naples 36
Tianjin 35
Amman 34
Orem 34
Buffalo 33
Nairobi 33
Turin 33
Bishkek 32
Dublin 32
Kampala 32
Luanda 32
Baku 30
Nanchang 30
London 29
Tokyo 29
Haiphong 28
Hebei 28
Libreville 28
Willemstad 28
Praia 27
Ulan Bator 27
Phnom Penh 26
Vientiane 26
Chennai 25
Florence 25
Jinan 25
Managua 25
Norwalk 25
Rio de Janeiro 25
Warsaw 25
Addis Ababa 24
Bologna 24
Dallas 24
Harare 24
Istanbul 24
Abidjan 23
Accra 23
Changsha 23
Da Nang 23
Guatemala City 23
Jiaxing 23
Nouakchott 23
Panama City 23
Podgorica 23
Riga 23
Turku 23
Brooklyn 22
Dushanbe 22
Frankfurt am Main 22
Hefei 22
Johannesburg 22
Lahore 22
Lusaka 22
Maputo 22
Minsk 22
Riyadh 22
Shanghai 22
Stockholm 22
Totale 16.531
Nome #
Metabolismo Proteico 1.075
Aminoacidi essenziali: principali determinanti della nutrizione e dell'impronta ambientale 352
Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin. 309
A Multifunctional Bread Rich in Beta Glucans and Low in Starch Improves Metabolic Control in Type 2 Diabetes: A Controlled Trial 283
Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy 273
Lumican is overexpressed in lung adenocarcinoma pleural effusions. 269
Effect of liver cirrhosis on phenylalanine and tyrosine metabolism 262
Essential amino acids: master regulators of nutrition and environmental footprint? 256
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 255
No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. 253
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 252
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy 251
Delta2D and Proteomweaver: Performance evaluation of two different approaches for 2-DE analysis 248
Middle age is not associated with altered fibrinogen concentration and production in males. 248
Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man. 247
Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach. 241
Kinetics of albumin homocysteinylation measured with matrix-assisted laser/desorption ionization mass spectrometry versus with a radioactive tracer. 240
Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. 240
Improved instrumentation for large-size two-dimensional protein maps 239
Effects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings. 238
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 232
Caldesmon over-expression in type 1 diabetic nephropathy 229
A rapid method to determine plasma homocysteine concentration and enrichment by gas chromatography/mass spectrometry. 225
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 224
Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin 223
Decreased Homocysteine Trans-Sulfuration in Hypertension With Hyperhomocysteinemia: Relationship With Insulin Resistance 223
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study 222
Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus 221
Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects 218
The inter- and intra-operator variability in manual spot segmentation and its effect on spot quantitation in two-dimensional electrophoresis analysis. 217
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population. 215
High confidence and sensitivity four-dimensional fractionation for human plasma proteome analysis. 210
Effect of Reversal of the Whey protein to casein ratio of cow milk on insulin and incretin responses in humans 210
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. 209
SDS-PAGE and two-dimensional maps in a radial gel format. 209
Effects of CK2 inhibition in cultured fibroblasts from Type 1 Diabetic patients with or without nephropathy 209
Dose-response curves of effects of insulin on leucine kinetics in humans. 204
VLDL-Apo B 100 fractional synthesis rate (FSR) is decreased in type 2 diabetes mellitus patients with diabetic nephropathy and hypertriglyceridaemia: possible defect in VLDL-Apo B 100 removal 202
The contribution of muscle, kidney, and splanchnic tissues to leucine transamination in humans. 201
Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. 200
Sample loading influences studies comparing isoelectric focusing vs. strong cation exchange peptide fractionation 199
Roles of insulin, age, and asymmetric dimethylarginine, on nitric oxide synthesis in vivo. 195
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 194
Leucine and phenylalanine kinetics during mixed meal ingestion: a multiple tracer approach. 193
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 192
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 192
Insulin on methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models 192
Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes 190
The Effects of Rosiglitazone and High Glucose on Protein Expression in Endothelial Cells 190
Leucine Transamination Is Lower in Middle-Aged Compared with Younger Adults. 189
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 187
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. PMID: 16186400 187
Are there dietary requirements for dispensable amino acids and if so, how do we assess requirements? 186
Effect of reversal of whey-protein to casein ratio of cow milk, on insulin, incretin and amino acid responses in humans 186
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy 184
Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes 181
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 179
Neither Incretin or Amino Acid Responses, nor Casein Content, Account for the Equal Insulin Response Following Iso-Lactose Loads of Natural Human and Cow Milk in Healthy Young Adults 179
Insulin resistance of amino acid and protein metabolism in type 2 diabetes 177
Reduced in vivo biological activity of in vitro glycosylated insulin. 177
La Dieta Sostenibile 177
Rapid, simple and effective technical procedure for the regeneration of IgG and HSA affinity columns for proteomic analysis. 177
Compartmental model of leucine kinetics in humans 176
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 175
Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides. 175
Polar electrophoresis: shape of two-dimensional maps is as important as size. 173
A fast high-performance liquid chromatographic method for the measurement of plasma concentration and specific activity of phenylalanine. 173
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 173
A High-Fiber Diet Decreases Postabsorptive Protein Turnover but Does Not Alter Insulin Sensitivity in Men with Type 1 Diabetes Mellitus. 173
Nitric oxide in the normal kidney and in patients with diabetic nephropathy. 170
Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy 167
Evidence for acute stimulation of fibrinogen production by glucagon in humans. 167
Pros and cons of peptide isolectric focusing in shotgun proteomics 166
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 164
Effects of Low-Protein, and Supplemented Very Low-Protein Diets, on Muscle Protein Turnover in Patients With CKD. 164
La guerra delle etichette tra Italia e Europa. Cosa dice la Scienza? 162
Phenylalanine hydroxylation across the kidney in humans 161
Ketoacidosis in diabetic subjects treated with inhibitors of Na(+)-glucose co-transporters type-2: New mechanisms? 160
Alpha cell autoantibodies: immunological and metabolic follow-up study. 159
Environmental footprint of vegetal and animal based foods in relation to the nutritional requirements of the human body 159
Effects of insulin and amino acid infusion on leucine and phenylalanine kinetics in type 1 diabetes. 156
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 156
Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. 155
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 153
Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes. 153
Hyperglucagonemia stimulates phenylalanine oxidation in man. 152
A model of skeletal muscle leucine kinetics across the human forearm 152
Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. 150
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 149
Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon. 148
Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. 148
Kidney, splanchnic and leg protein turnover in humans: insight from leucine and phenylalanine kinetics. 147
Mechanisms of post-prandial protein accretion in human skeletal muscle: insight from leucine and phenylalanine forearm kinetics. 147
Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans. 147
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 147
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 146
Operator- and software-related post-experimental variability and source of error in 2-DE analysis. 146
Effects of insulin on whole-body and regional amino acid metabolism. 141
Plasma protein synthesis in patients with low-grade nephrotic proteinuria 141
La Nutrizione Artificiale (NA) nel diabete mellito. Parte prima: Fisiologia del metabolismo dei substrati in corso di NA ed effetti del diabete 141
Totale 20.429
Categoria #
all - tutte 68.296
article - articoli 62.832
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 1.360
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.473
Totale 134.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021341 0 0 0 0 0 0 0 0 0 0 181 160
2021/20221.871 44 214 223 138 69 106 76 192 89 48 210 462
2022/20231.437 323 161 31 162 215 158 6 109 174 22 55 21
2023/20241.271 42 98 113 53 75 141 68 128 96 144 164 149
2024/20253.038 50 245 181 182 433 99 117 230 183 108 507 703
2025/202611.250 487 942 1.463 1.754 1.168 567 1.510 1.118 1.221 717 303 0
Totale 25.767